Table 1. Patient characteristics among 390 patients treated with curatively intended oesophagectomy for cancer who survived for at least 1 year.
Number of complications* | Total | |||
---|---|---|---|---|
0 | 1 | >1 | ||
Total (N (%)) | 221 (57) | 94 (24) | 75 (19) | 390 (100) |
Age (years) | ||||
<60 | 59 (27) | 24 (26) | 22 (29) | 105 (27) |
60–74 | 125 (57) | 51 (54) | 43 (57) | 219 (56) |
≥75 | 37 (17) | 19 (20) | 10 (13) | 66 (17) |
Sex | ||||
Male | 173 (78) | 77 (82) | 62 (83) | 312 (80) |
Female | 48 (22) | 17 (18) | 13 (17) | 78 (20) |
Comorbidities (number) | ||||
0 | 77 (35) | 34 (36) | 18 (24) | 129 (33) |
1 | 88 (40) | 31 (33) | 28 (37) | 147 (38) |
>1 | 56 (25) | 29 (31) | 29 (39) | 114 (29) |
Tumour stage^ | ||||
0-I | 43 (19) | 22 (24) | 25 (34) | 90 (23) |
II | 81 (37) | 34 (37) | 18 (24) | 133 (34) |
III | 86 (39) | 28 (30) | 23 (31) | 137 (35) |
IV | 11 (5) | 9 (10) | 8 (11) | 28 (7) |
Histological type of tumour | ||||
Adenocarcinoma | 170 (77) | 75 (80) | 52 (69) | 297 (76) |
Squamous cell carcinoma | 51 (23) | 19 (20) | 23 (31) | 93 (24) |
Hospital volume | ||||
<15 oesophagectomies/year | 145 (66) | 60 (64) | 52 (69) | 257 (66) |
≥15 oesophagectomies/year | 76 (34) | 34 (36) | 23 (31) | 133 (34) |
Neoadjuvant therapy | ||||
Yes | 25 (11) | 12 (13) | 6 (8) | 43 (11) |
No | 196 (89) | 82 (87) | 69 (92) | 347 (89) |
Survival time in days | ||||
Median | 747 | 516 | 378.5 | |
Interquartile range | 324–1826 | 267–1751 | 150–1231 | |
Discharge to 1 year after oesophagectomy | ||||
Days of in-hospitalisation (interquartile range) | 5 (0–16) | 8 (0–20) | 9 (0–25) | |
Number of hospitalisations (interquartile range) | 1 (0–2) | 1 (0–2) | 1 (0–3) | |
Number of outpatient visits (interquartile range) | 5 (3–9) | 6 (4–10) | 6 (3–10) | |
Year 1–5 after oesophagectomy | ||||
Days of in-hospitalisation (interquartile range) | 16 (1–39) | 14 (2–37) | 15 (4–44) | |
Number of hospitalisations (interquartile range) | 2 (1–4) | 2 (1–4) | 2 (1–4) | |
Number of outpatient visits (interquartile range) | 6 (3–13) | 6 (2–16) | 8 (4–18) |
^2 missing values.
*Only major complications causing clinical symptoms, as defined in the method section are included.